The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of talazoparib and avelumab in VHL deficient clear cell renal cell carcinoma.
 
Ritesh Kotecha
Consulting or Advisory Role - Eisai
Research Funding - Pfizer (Inst); Takeda (Inst)
 
Chung-Han Lee
Honoraria - American Institute of Continuing Medical Education; Intellisphere; Research to Practice
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Exelixis; Merck; Pfizer/EMD Serono
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Eisai (Inst); Exelixis (Inst); Merck (Inst)
 
Deaglan Joseph McHugh
Consulting or Advisory Role - Progenics
 
Chloe Dadoun
No Relationships to Disclose
 
Andrea Knezevic
Consulting or Advisory Role - ByHeart
 
Maria Isabel Carlo
Other Relationship - Prostate Cancer Foundation; Robert Wood Johnson Foundation
 
Emily Feld
No Relationships to Disclose
 
Natalie Shapnik
No Relationships to Disclose
 
Neil J. Shah
Consulting or Advisory Role - Merck Sharp & Dohme Corp.
Research Funding - Aravive (Inst)
 
Darren R. Feldman
Research Funding - Astellas Pharma; Decibel Therapeutics (Inst); Novartis; Seagen
Other Relationship - UpToDate
 
Robert J. Motzer
Consulting or Advisory Role - AstraZeneca; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Genentech/Roche; Incyte; Lilly; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Martin H Voss
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - AVEO; Calithera Biosciences; Corvus Pharmaceuticals; Eisai; Exelixis; Merck; Pfizer
Research Funding - Pfizer
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
Other Relationship - BMS
(OPTIONAL) Uncompensated Relationships - Aravive; BMS; Genentech/Roche